Startseite>>Signaling Pathways>> Others>>1,4,7-Triazonane

1,4,7-Triazonane

Katalog-Nr.GC64247

1,4,7-Triazonan (1,4,7-Triazacyclononan), ein Zwischenprodukt bei der Synthese von 1,4,7-trifunktionalisierten Derivaten, ist ein mÖgliches Reagenz fÜr kompleximetrische Titrationen mit hoher KationenbindungsselektivitÄt[2 ].

Products are for research use only. Not for human use. We do not sell to patients.

1,4,7-Triazonane Chemische Struktur

Cas No.: 4730-54-5

Größe Preis Lagerbestand Menge
100 mg
54,00 $
Auf Lager
500 mg
135,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1,4,7-Triazonane (1,4,7-Triazacyclononane), an intermediate in the synthesis of 1,4,7-trifunctionalized derivatives, is a possible reagent for compleximetric titrations with high cation-binding selectivity[1][2].

1,4,7-Triazonane is an intermediate in the synthesis of 1,4,7-trifunctionalized derivatives that have applications in metal complexation[2].

[1]. Nonat A, et, al. Structural and photophysical studies of highly stable lanthanide complexes of tripodal 8-hydroxyquinolinate ligands based on 1,4,7-triazacyclononane. Inorg Chem. 2009 May 4;48(9):4207-18.
[2]. Guo JF, et, al. trans-[Os(III)(salen)(CN)(2)](-): a new paramagnetic building block for the construction of molecule-based magnetic materials. Inorg Chem. 2010 Feb 15;49(4):1607-14.

Bewertungen

Review for 1,4,7-Triazonane

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1,4,7-Triazonane

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.